# OncoDecipher

**Source:** https://www.startuphub.ai/startups/oncodecipher
**Profile type:** Startup

> OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

## About

OncoDecipher is a life sciences company focused on developing novel diagnostic tools for cancer. Their proprietary technology analyzes silent mutations within cancer genomes to predict a patient's specific cancer type and their probability of survival, aiming to improve personalized treatment strategies.

## Key facts

- **Slug:** oncodecipher
- **Website:** https://www.oncdecipher.com/
- **Location:** Cambridge, United States
- **Founded:** 2015-01-01
- **Operating status:** Inactive
- **Total funding:** $1M
- **Sectors / tags:** Life Sciences, Cancer, Oncology, Mutation, Genomics, Biotech, HealthTech, Drug Discovery, Clinical Trials, Precision Medicine, AI-Driven Drug Discovery

## Frequently asked

### What does OncoDecipher do?

OncoDecipher is a life sciences company focused on developing novel diagnostic tools for cancer. Their proprietary technology analyzes silent mutations within cancer genomes to predict a patient's specific cancer type and their probability of survival, aiming to improve personalized treatment strategies.

### What is OncoDecipher's revenue?

StartupHub estimates OncoDecipher's annual revenue at $282K (range $68K to $425K, 27% confidence), based on comparable companies in the sector.

### What is OncoDecipher's valuation?

StartupHub estimates OncoDecipher's effective valuation at $3.8M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.

### How much funding has OncoDecipher raised?

OncoDecipher has raised a total of $1M in funding. The most recent round on record is Seed.

### Where is OncoDecipher headquartered?

OncoDecipher is headquartered in Cambridge, United States.

### When was OncoDecipher founded?

OncoDecipher was founded in 2015.

### What industry does OncoDecipher operate in?

OncoDecipher operates in Life Sciences, Cancer, Oncology, Mutation, Genomics, Biotech.

### What is OncoDecipher's current status?

OncoDecipher's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "OncoDecipher",
          "item": "https://www.startuphub.ai/startups/oncodecipher"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/oncodecipher#webpage",
      "url": "https://www.startuphub.ai/startups/oncodecipher",
      "name": "OncoDecipher - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of OncoDecipher. OncoDecipher is a startup founded in 2015, operating in Life Sciences and Cancer. OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. Headquartered in Cambridge, United States.",
      "dateModified": "2026-07-26T06:00:52.483+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/oncodecipher#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/oncodecipher#organization",
      "name": "OncoDecipher",
      "url": "https://www.oncdecipher.com/",
      "description": "This is the official profile of OncoDecipher. OncoDecipher is a startup founded in 2015, operating in Life Sciences and Cancer. OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. Headquartered in Cambridge, United States.",
      "sameAs": [
        "https://www.startuphub.ai/startups/oncodecipher"
      ],
      "foundingDate": "2015-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Life Sciences",
        "Cancer",
        "Oncology",
        "Mutation",
        "Genomics",
        "Biotech",
        "HealthTech",
        "Drug Discovery",
        "Clinical Trials",
        "Precision Medicine",
        "AI-Driven Drug Discovery"
      ]
    }
  ]
}
```